EWTX - Edgewise Therapeutics Non-GAAP EPS of $0.47
2024-02-22 13:40:40 ET
More on Edgewise Therapeutics
- Edgewise Therapeutics: Behind The Massive Rally
- Edgewise: DMD Data In The First Half Of 2024 Could Lead To Additional Testing
- Krystal Biotech, Candel, Edgewise gain after FDA fast track tags
- Edgewise wins FDA orphan drug status for muscle disorder therapy
- Seeking Alpha’s Quant Rating on Edgewise Therapeutics